Shaneice Mitchell

576 total citations
8 papers, 47 citations indexed

About

Shaneice Mitchell is a scholar working on Hematology, Molecular Biology and Cancer Research. According to data from OpenAlex, Shaneice Mitchell has authored 8 papers receiving a total of 47 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 5 papers in Molecular Biology and 2 papers in Cancer Research. Recurrent topics in Shaneice Mitchell's work include Acute Myeloid Leukemia Research (4 papers), Protein Degradation and Inhibitors (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Shaneice Mitchell is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Protein Degradation and Inhibitors (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Shaneice Mitchell collaborates with scholars based in United States and United Kingdom. Shaneice Mitchell's co-authors include Siddhartha Jaiswal, Sharyn D. Baker, Erin Hertlein, Rosa Lapalombella, John C. Byrd, Ola A. Elgamal, Amy Lehman, Sudharshan Eathiraj, Shelley Orwick and Kimberly Stegmaier and has published in prestigious journals such as Blood, Current Opinion in Genetics & Development and Nature Reviews Cardiology.

In The Last Decade

Shaneice Mitchell

8 papers receiving 46 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shaneice Mitchell United States	4	27	22	17	12	8	8	47
Phillip Michaels United States	4	19 0.7×	10 0.5×	13 0.8×	28 2.3×	10 1.3×	12	63
Neus Ruiz‐Xivillé Spain	6	15 0.6×	10 0.5×	15 0.9×	16 1.3×	8 1.0×	8	34
Sonia Fox United Kingdom	4	13 0.5×	22 1.0×	20 1.2×	20 1.7×	11 1.4×	11	41
Oana Stanca Romania	4	35 1.3×	20 0.9×	17 1.0×	4 0.3×	9 1.1×	9	51
Eirini S. Fasouli Greece	3	24 0.9×	50 2.3×	15 0.9×	6 0.5×	26 3.3×	4	89
Giuseppe Sapienza Italy	5	43 1.6×	13 0.6×	23 1.4×	6 0.5×	23 2.9×	14	73
Amy Saur United States	4	19 0.7×	36 1.6×	25 1.5×	18 1.5×	16 2.0×	5	62
Francis Baumgartner Germany	2	10 0.4×	31 1.4×	9 0.5×	9 0.8×	15 1.9×	3	44
Thomas Cummin United Kingdom	4	13 0.5×	32 1.5×	9 0.5×	16 1.3×	18 2.3×	6	46
Erin Brophy United States	3	8 0.3×	16 0.7×	21 1.2×	9 0.8×	4 0.5×	3	39

Countries citing papers authored by Shaneice Mitchell

Since Specialization

Citations

This map shows the geographic impact of Shaneice Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaneice Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaneice Mitchell more than expected).

Fields of papers citing papers by Shaneice Mitchell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaneice Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaneice Mitchell. The network helps show where Shaneice Mitchell may publish in the future.

Co-authorship network of co-authors of Shaneice Mitchell

This figure shows the co-authorship network connecting the top 25 collaborators of Shaneice Mitchell. A scholar is included among the top collaborators of Shaneice Mitchell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaneice Mitchell. Shaneice Mitchell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Weng, Ziming, Shaneice Mitchell, Daniel Nachun, et al.. (2023). Multi-Omic Profiling of Macrophages Lacking Tet2 or Dnmt3a Reveals Mechanisms of Hyper-Inflammation in Clonal Hematopoiesis. Blood. 142(Supplement 1). 1163–1163. 3 indexed citations

Tcheandjieu, Catherine, et al.. (2022). Black In Cardio: promoting diversity and representation in the cardiovascular field. Nature Reviews Cardiology. 19(11). 717–718. 1 indexed citations

Mitchell, Shaneice, Bonnie K. Harrington, Shelley Orwick, et al.. (2022). The Multi-CDK Inhibitor Dinaciclib Shows Synergistic Activity with the BET Inhibitor PLX51107 and Reverses BET Resistance through Inhibition of Canonical Wnt Signaling in Acute Myeloid Leukemia (AML). Blood. 140(Supplement 1). 3075–3076. 1 indexed citations

Mitchell, Shaneice, et al.. (2021). Insights into clonal hematopoiesis and its relation to cancer risk. Current Opinion in Genetics & Development. 66. 63–69. 21 indexed citations

Elgamal, Ola A., Amy Lehman, Shelley Orwick, et al.. (2020). Preclinical efficacy for a novel tyrosine kinase inhibitor, ArQule 531 against acute myeloid leukemia. Journal of Hematology & Oncology. 13(1). 8–8. 14 indexed citations

Grieselhuber, Nicole R., Shaneice Mitchell, Shelley Orwick, et al.. (2016). The Novel BET Inhibitor PLX51107 Has In Vitro and In Vivo Activity Against Acute Myeloid Leukemia. Blood. 128(22). 3941–3941. 5 indexed citations

Mitchell, Shaneice, Shelley Orwick, Matthew Cannon, et al.. (2015). In Vitro and In Vivo Anti-Leukemic Effects of KPT-9274, a Reported PAK4 Allosteric Modulator, in Acute Myeloid Leukemia: Promising Results Justifying Further Development in This Disease. Blood. 126(23). 2471–2471. 1 indexed citations

Taylor, Kerry, R. Rodwell, Debra L. Taylor, et al.. (1995). Normal (RT-PCR negative) stem cells can be collected following lenograstim therapy in chronic myeloid leukemia (CML) in major/complete cytogenetic response (MCR/CCR) on alpha-interferon (alpha-IFN).. Blood. 86(10). 3955–3955. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact